Uncovering the Truth: Kaplan Fox Kilsheimer LLP Launches Investigation into Eagle Pharmaceuticals Inc. (NASDAQ: EGRX)

Kaplan Fox & Kilsheimer LLP Investigates Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) The Investigation NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP is investigating potential claims on behalf of investors who purchased securities of Woodcliff Lake, New Jersey-based Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”). If you purchased Eagle…

Read More

Attention Shareholders: Levi & Korsinsky Notifies Investors of Class Action Lawsuit and Upcoming Deadline for The Beauty Health Company (SKIN)

SHAREHOLDER ALERT: Levi & Korsinsky Notifies The Beauty Health Company Investors of a Class Action Lawsuit New York, Nov. 29, 2023 (GLOBE NEWSWIRE) Overview Levi & Korsinsky, LLP, a leading securities litigation firm, has announced that it is notifying investors in The Beauty Health Company (NASDAQ: SKIN) about a class action securities lawsuit. The lawsuit…

Read More

Calling All Clever Leaves Holdings Inc. (CLVR) Investors: Contact Bronstein Gewirtz & Grossman LLC to Claim Your Losses

Calling All Clever Leaves Holdings Inc. (CLVR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC New York, Nov. 29, 2023 (GLOBE NEWSWIRE) — Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is currently investigating potential claims on behalf of purchasers of Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“Schultze”), which completed a merger with…

Read More

Uncovering Potential Breaches of Fiduciary Duty: Investigating Orthofix Medical Inc. (NASDAQ: OFIX) by Lowey Dannenberg P.C.

Lowey Dannenberg, P.C. Investigating Potential Breach of Fiduciary Duty at Orthofix Medical Inc. New York, Nov. 29, 2023 (GLOBE NEWSWIRE) — Lowey Dannenberg P.C., a leading law firm known for seeking justice for consumers and investors, is currently looking into a potential breach of fiduciary duty claim involving the board of directors of Orthofix Medical…

Read More

Uncovering Potential Securities Violations: Lowey Dannenberg P.C. Investigates R1 RCM Inc. (RCM) on NASDAQ

NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) — Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating R1 RCM Inc. (“RCM” or the “Company”) (NASDAQ: RCM) for potential violations of the federal securities laws. If you are an RCM shareholder and have lost over $100,000 in investments, you…

Read More

Join Us at COP 28: African Private Sector Reception for Sustainable Development Strategies!

Welcome to the African Private Sector Reception at COP 28! Event Details: What: Africa Private Sector Reception Where: Jumeirah Mina A’Salam Hotel, Dubai When: 16:00 – 18:00 on Friday 1st December Registration: Please register here The African Private Sector Reception at COP 28, jointly hosted by the UN Global Compact Africa Business Leaders Coalition (ABLC)…

Read More

Attention Investors: Abbott Cooper PLLC Launches Investigation into Crown Castle Inc. – Take Action Now to Protect Your Legal Rights!

Investigation into Crown Castle, Inc. Abbott Cooper PLLC Investigates Alleged Fiduciary Duty Violations STAMFORD, Conn., Nov. 29, 2023 (GLOBE NEWSWIRE) — Abbott Cooper PLLC is currently conducting an investigation into Crown Castle, Inc. (NYSE: CCI) on behalf of the Company’s investors. The investigation aims to determine whether Crown Castle’s Board of Directors has breached its…

Read More

Breaking Boundaries: Selas Life Sciences Achieves Target Enrollment in Phase 3 Regal Trial for Galinpepimut-S in Acute Myeloid Leukemia, Excluding China

Independent Data Monitoring Committee Scheduled to Meet This Quarter SELLAS Life Sciences Reaches Target Enrollment ex-China in Phase 3 REGAL Trial of Galinpepimut-S in Acut… New York, Nov. 29, 2023 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel…

Read More